PMC Links for Gene (Select 26038) - PMC

Ilaria Parenti, Daphné Lehalle, Caroline Nava, Erin Torti, Elsa Leitão, Richard Person, Takeshi Mizuguchi, Naomichi Matsumoto, Mitsuhiro Kato, Kazuyuki Nakamura, Stella A. de Man, Heidi Cope, Vandana Shashi, Undiagnosed Diseases Network, Jennifer Friedman, Pascal Joset, Katharina Steindl, Anita Rauch, Irena Muffels, Peter M. van Hasselt, Florence Petit, Thomas Smol, Gwenaël Le Guyader, Frédéric Bilan, Arthur Sorlin, Antonio Vitobello, Christophe Philippe, Ingrid M. B. H. van de Laar, Marjon A. van Slegtenhorst, Philippe M. Campeau, Ping Yee Billie Au, Mitsuko Nakashima, Hirotomo Saitsu, Tatsuya Yamamoto, Yumiko Nomura, Raymond J. Louie, Michael J. Lyons, Amy Dobson, Astrid S. Plomp, M. Mahdi Motazacker, Frank J. Kaiser, Andrew T. Timberlake, Sabine A. Fuchs, Christel Depienne, Cyril Mignot

Hum Genet. 2021; 140(7): 1109–1120. Published online 2021 May 4. doi: 10.1007/s00439-021-02283-2

PMCID:: PMC8197709

Abstract Article PDF–2.0M

Select item 75425314.

Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways

Sheng Huang, Qitao Yan, Shilin Xiong, Yiqi Peng, Rui Zhao, Chunxiao Liu

Biomed Res Int. 2020; 2020: 5425612. Published online 2020 Sep 28. doi: 10.1155/2020/5425612

PMCID:: PMC7542531

Abstract Article PDF–2.5M

Select item 60031425.

A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk

Qin Xiao, Lianzhou Chen, Haiqing Luo, Hongmei Li, Qingming Kong, Fei Jiao, Shifeng Pang, Ming Zhang, Feifei Lan, Wenguo Fan, Hui Luo, Tao Tao, Xiao Zhu

BMC Cancer. 2018; 18: 658. Published online 2018 Jun 15. doi: 10.1186/s12885-018-4551-y

PMCID:: PMC6003142

Abstract Article PDF–984K

Select item 50083106.

The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation

Zhenfang Du, Lili Li, Xin Huang, Jie Jin, Suming Huang, Qian Zhang, Qian Tao

Oncotarget. 2016 Apr 19; 7(16): 21618–21630. Published online 2016 Mar 1. doi: 10.18632/oncotarget.7822

PMCID:: PMC5008310

Abstract Article PDF–12M

Select item 41102827.

The Tumor Suppressor Chromodomain Helicase DNA-binding Protein 5 (CHD5) Remodels Nucleosomes by Unwrapping

Jinhua Quan, Timur Yusufzai

J Biol Chem. 2014 Jul 25; 289(30): 20717–20726. Published online 2014 Jun 12. doi: 10.1074/jbc.M114.568568

PMCID:: PMC4110282

Abstract Article PDF–1.1M

Select item 39473278.

Epigenetic silencing of CHD5, a novel tumor suppressor gene, occurs in early colorectal cancer stages

Mehrnaz Fatemi, Thomas A. Paul, Garrett M. Brodeur, Babak Shokrani, Hassan Brim, Hassan Ashktorab

Cancer. Author manuscript; available in PMC 2015 Jan 15.

Published in final edited form as: Cancer. 2014 Jan 15; 120(2): 172–180. Published online 2013 Nov 14. doi: 10.1002/cncr.28316

PMCID:: PMC3947327

Abstract Article PDF–4.1M

Select item 38903159.

Silencing of CHD5 Gene by Promoter Methylation in Leukemia

Rui Zhao, Fanyi Meng, Nisha Wang, Wenli Ma, Qitao Yan

PLoS One. 2014; 9(1): e85172. Published online 2014 Jan 13. doi: 10.1371/journal.pone.0085172

PMCID:: PMC3890315

Abstract Article PDF–3.8M

Select item 344633510.

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer

Xiao Wu, Zhengmao Zhu, Weidong Li, Xiaoying Fu, Dan Su, Liya Fu, Zhiqian Zhang, Ang Luo, Xiaodong Sun, Li Fu, Jin-Tang Dong

Breast Cancer Res. 2012; 14(3): R73. Published online 2012 May 8. doi: 10.1186/bcr3182

PMCID:: PMC3446335

Abstract Article PDF–3.6M

Select item 330648711.

Mechanisms of CHD5 Inactivation in Neuroblastomas

Hiroshi Koyama, Tiangang Zhuang, Jennifer E. Light, Venkatadri Kolla, Mayumi Higashi, Patrick W. McGrady, Wendy B. London, Garrett M. Brodeur

Clin Cancer Res. Author manuscript; available in PMC 2013 Mar 15.

Published in final edited form as: Clin Cancer Res. 2012 Mar 15; 18(6): 1588–1597. Published online 2012 Jan 31. doi: 10.1158/1078-0432.CCR-11-2644

PMCID:: PMC3306487

Abstract Article PDF–524K

Select item 299202912.

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

Idoia Garcia, Gemma Mayol, Eva Rodríguez, Mariona Suñol, Timothy R Gershon, José Ríos, Nai-Kong V Cheung, Mark W Kieran, Rani E George, Antonio R Perez-Atayde, Carla Casala, Patricia Galván, Carmen de Torres, Jaume Mora, Cinzia Lavarino

Mol Cancer. 2010; 9: 277. Published online 2010 Oct 15. doi: 10.1186/1476-4598-9-277

PMCID:: PMC2992029

Abstract Article PDF–5.2M

Select item 298035313.

The Quest for the 1p36 Tumor Suppressor

Anindya Bagchi, Alea A. Mills

Cancer Res. Author manuscript; available in PMC 2010 Nov 12.

Published in final edited form as: Cancer Res. 2008 Apr 15; 68(8): 2551–2556. doi: 10.1158/0008-5472.CAN-07-2095

PMCID:: PMC2980353

Abstract Article PDF–128K

Select item 277051014.

CHD5 is down-regulated through promoter hypermethylation in gastric cancer

Xian Wang, Kenneth KK Lau, Leo KY So, Yun Wah Lam

J Biomed Sci. 2009; 16(1): 95. Published online 2009 Oct 19. doi: 10.1186/1423-0127-16-95

PMCID:: PMC2770510

Abstract Article PDF–780K

Select item 248357415.

CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas

Tomoyuki Fujita, Jun Igarashi, Erin R. Okawa, Takahiro Gotoh, Jayanthi Manne, Venkatadri Kolla, Jessica Kim, Huaqing Zhao, Bruce R. Pawel, Wendy B. London, John M. Maris, Peter S. White, Garrett M. Brodeur

J Natl Cancer Inst. 2008 Jul 2; 100(13): 940–949. Published online 2008 Jul 2. doi: 10.1093/jnci/djn176

PMCID:: PMC2483574

Abstract Article PDF–566K

Select item 477076816.

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma

Lei Yu, Xuejun Gong, Lei Sun, Hong Yao, Baoling Lu, Liying Zhu

Oncotarget. 2015 Nov 17; 6(36): 39225–39234. Published online 2015 Jul 30. doi: 10.18632/oncotarget.4407

PMCID:: PMC4770768

Abstract Article PDF–3.8M

Select item 257060117.

Mutation and Methylation Analysis of the Chromodomain-Helicase-DNA Binding 5 Gene in Ovarian Cancer

Kylie L Gorringe, David YH Choong, Louise H Williams, Manasa Ramakrishna, Anita Sridhar, Wen Qiu, Jennifer L Bearfoot, Ian G Campbell

Neoplasia. 2008 Nov; 10(11): 1253–1258. doi: 10.1593/neo.08718

PMCID:: PMC2570601

Abstract Article PDF–1.0M

Select item 574628618.

Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5

Guangru Xu, Hongxing Zhu, Minghui Zhang, Jinhua Xu

Int J Mol Med. 2018 Jan; 41(1): 155–163. Published online 2017 Oct 31. doi: 10.3892/ijmm.2017.3225

PMCID:: PMC5746286

Abstract Article PDF–1.4M

Select item 424097519.

A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

Idoia Garcia, Gemma Mayol, José Ríos, Gema Domenech, Nai-Kong V. Cheung, André Oberthuer, Matthias Fischer, John M. Maris, Garrett M. Brodeur, Barbara Hero, Eva Rodríguez, Mariona Suñol, Patricia Galvan, Carmen de Torres, Jaume Mora, Cinzia Lavarino

Clin Cancer Res. Author manuscript; available in PMC 2014 Nov 22.

Published in final edited form as: Clin Cancer Res. 2012 Apr 1; 18(7): 2012–2023. Published online 2012 Feb 10. doi: 10.1158/1078-0432.CCR-11-2483

PMCID:: PMC4240975

Abstract Article PDF–1.0M

Select item 325047720.

MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5

Chunxiao Cai, Hassan Ashktorab, Xiaowu Pang, Yuan Zhao, Wei Sha, Yulan Liu, Xinbin Gu

PLoS One. 2012; 7(1): e29750. Published online 2012 Jan 3. doi: 10.1371/journal.pone.0029750

PMCID:: PMC3250477

Abstract Article PDF–434K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Gene

Items: 1 to 20 of 52

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity